NIH-wide Doctoral Partnership Training Program - University of Cambridge
Health and Human Services (all) · ASA OFFICE OF THE ASSISTANT SECRETARY FOR ADMINISTRATION
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 7571PS26Q00128 in this department, oldest first.
- Sep 22, 2026 · this noticePre-solicitation
- Sep 23, 2026Pre-solicitationOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION 7571PS26Q00128 Title: NIH-wide Doctoral Partnership Training Program - University of Cambridge (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in part 12 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The Solicitation number is 7571PS26Q00128 issued as a Request for Quotation to support the Doctoral Partnership Training Program at the Unive… (show all)
rsity of Cambridge. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The Office of Mission Acquisition Solutions (OMAS), Office of Acquisitions (OA), on behalf of The National Institute on Allergy Infectious Diseases (NIAID), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to University of Cambridge, Research Operations Office, Greenwich House, Madingley Road, Cambridge CB3-0TX, United Kingdom for the NIH Fellows roster. This acquisition is conducted as non-competitive for a commercial product or commercial service and is conducted pursuant to FAR Subpart 12.201-1�Simplified Procedures, in accordance with 41 United States Code (U.S.C.) 1901 Simplified acquisition procedures Pursuant to FAR subpart 12.102(b) Restricting Competition, in accordance with FAR 6.103-1(b) (ii) This requirement is for the following services: The National Institutes of Health (NIH) Division of Medical Sciences, the University of Cambridge of the United Kingdom, and the NIH-wide Global Doctoral Partnership (NGDP) Program have a shared interest in fostering collaborative research. The NIH provides, through its offices and investigators, the recruitment of exceptional students from the United States who will carry out graduate-level training and research for the 2025-2026 academic year under coordinated mentors at the NIH and University of Cambridge. This acquisition seeks to cover the tuition fees for both new (incoming) and continuing students in the program for the 2025-2026 academic year. The program of study shall include co-supervision for trainees at the University and the NIH. Basic and applied research shall be carried out by the trainees at both institutions. Only this suggested source can furnish the requirements: University of Cambridge Research Operations Office Greenwich House Madingley Road Cambridge CB3 0TX UNITED KINGDOM (iii) Description of requirement: The University of Cambridge shall provide 33 graduate-level training and research for students for the 2026-2027 academic year. In addition to administrative oversight, the University shall provide for the following functions: Shared core values (NIH and University) Advance the NIH mission of global outreach and training by contributing internationally collaborative research in areas of emerging and infectious disease, global health, and international medicine. Common government pursuit of public health care and health care initiatives. University requirements The partnering University must have a tutorial system where faculty fellows teach students in groups of one to three on a weekly basis. The tutorial system is uniquely required for the student training in the International PhD Program because there is no formal didactic component required for degree completion. The tutorial system will allow students to receive direct feedback on their NIH projects. It will also provide an opportunity to discuss the published literature and to learn how to think critically like a scientist. University provides access to classes for students virtually online or safely in-person. Shared training between the NIH and the University. Students spend a maximum of two years at the partner institution. The remaining two years of PhD experiential work must be spent at the NIH. Demonstrated emphasis on quality research with supplemental coursework and skills enrichment opportunities available but not mandatory. The students in the graduate partnership program work collaboratively in any one of the 27 Institutes and centers that make up the NIH. These include but not limited to: NCI-CCR, NCI-DCEG, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NINDS, NLM, VRC, NCATS, CIT, NIEHS, CC. The degree conferring institution that partners with the NIH must have a pool of researchers that the research expertise found at the NIH. The partnering institution must have various schools and program that are available as training environments (centers). Demonstrated evidence of academic history of scientific research and training spanning seven to eight centuries. Common requirements for mentorship and training of graduate students. Demonstrated performance: evidence of students who have successfully completed doctoral degrees through a partnership-training program. Abundant opportunities to form collaborations between Principal Investigators based on common program missions and shared biomedical interests in global health and medicine. Existing network of published principal investigators. Common access to contemporary and technologically advanced research facilities. Opportunity for international collaboration and intellectual transfer without language barriers. English must be spoken exclusively in NIH laboratories. Infrastructure and staff dedicated to international training collaborations. Research specialties in infectious disease, cancer, immunology, neurology, vaccine research, genomics, child health, and human development. Clinical aspect integrated into graduate training with hospitals located on University campus. Administrative oversight Supervision of existing student participants who have been accepted into the NIH Oxford-Cambridge Scholars Program and who are continuing training for the 2025-2026 academic scholastic year. The 2026 scholastic enrollment of existing students shall consist of multiple participants. Reviewing University application packages for matriculating students to ensure that all admission documents have been received, reviewed, and validated. Informing students of Visa requirements. Notifying student program participants of his/her acceptance to the university and college. Provision of research opportunities in university laboratories with qualified faculty members who will serve as mentors and advisors to the students in the program. Participation and support of annual research colloquia and other program activities. Facilitation of the entry of U.S. students into the full college life of the University as members of the Colleges at the University. Provision of University housing for students in the program. (iv) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated period of performance will begin on or around 09/30/2026 through 09/29/2027 for one year. (v) The provisions at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide t
Who won similar work
874 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Health and Human Services (all)), any industry: a loose match.
Loose match: same agency, any industry. Read the titles before treating these as competitors.
Single-winner award sizes (805): middle half $79K to $4.9M, median $407K; range $1 to $89.0B.
| Winner | Awards | Value | Last |
|---|---|---|---|
| DT-TRAK CONSULTING, INC. | 15 | $23.1M | Sep 9, 2026 |
| LACREEK DEVELOPMENT CORP | 14 | $24.3M | Aug 5, 2026 |
| LYDAY CONSTRUCTION LLC | 14 | $508K | Sep 2, 2026 |
| BIGHORN RIDGERUNNERS, LLC | 10 | $2.2M | Jul 27, 2026 |
| Prime Physicians Tri Providers LLC | 7 | $110.0M | Sep 22, 2026 |
| RESEARCH TRIANGLE INSTITUTE Durham NC 27709 USA | 6 | $1.5B + 1 shared | Oct 5, 2026 |
| GOVERNMENT SCIENTIFIC SOURCE INC | 6 | $967K | Sep 11, 2026 |
| Tywell Builders LLC | 6 | $60K | Jun 10, 2025 |
| POLOLEI SOLUTIONS, LLC | 5 | $3.3M | Jul 21, 2026 |
| ALKO ENTERPRISES INC | 5 | $2.6M | Apr 27, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- Oct 13, 2026DATIX (USA) INC.$2.2MIHS Agency-wide Instructions for Use Subscription Services
- Oct 9, 2026Revvity Health Sciences, Inc.$21KAutomated Cell Counter and Analyzer
- Oct 8, 2026Please_See_Spreadsheet Silver Spring MD 20993 USA$120.8MFY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
- Oct 7, 2026SIA PARTNERS U.S., INC.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES
- Oct 7, 2026BCG FEDERAL CORP.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES
- Oct 7, 2026FISHER BIOSERVICES INC$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES
- Oct 7, 2026PPD DEVELOPMENT LP$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES
- Oct 7, 2026ADVANCED BIOSCIENCE LABORATORIES, INC.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES
- Oct 7, 2026AMERICAN TYPE CULTURE COLLECTION Manassas VA 20110 USA$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES
- Oct 6, 2026DevelopUs Worldwide, LLC$488KACF Lead Forward Leadership Development Framework
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Health & Human Services, Dept of (HHS) since 2024 (0 filings)
- 0 of their lobbyists list a past Health & Human Services, Dept of (HHS) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 252 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.